Factores de riesgo para adquirir la infección por el Virus del Papiloma Humano (VPH) y otras infecciones de transmisión sexual en mujeres estudiantes universitarias vacunadas y no vacunadas contra el VPH

Erika andrea Sanchez Cifuentes; Natalie Patiño Cardenas; Juliana Espinosa Moncada; Lorena Quintero Murillo; Astrid Bedoya

doi:10.17533/udea.hm.335032

Authors

Erika andrea Sanchez Cifuentes University of Antioquia
Natalie Patiño Cardenas University of Antioquia
Juliana Espinosa Moncada University of Antioquia
Lorena Quintero Murillo University of Antioquia
Astrid Bedoya University of Antioquia

DOI:

https://doi.org/10.17533/udea.hm.335032

Keywords:

cervical cancer, risky sexual behavior, sexually transmitted infections, human papillomavirus, HPV vaccine

Abstract

Introduction:Human Papillomavirus (HPV) infection is one of the most common Sexually Transmitted Infections (STIs) worldwide. Early initiation of sexual intercourse and a high number of sexual partners are the major risk factors for acquiring this and other STIs. Currently, vaccination against HPV is a major primary prevention strategy against this virus. The objective of this research was to describe the risk factors associated with HPV infection and other STIs in female university students, vaccinated and non-vaccinated against HPV infection.

Methods: this cross-sectional descriptive study included a survey applied to female university students older than 18 years of age who had received or not the vaccine against HPV. The survey contained 50 questions about socio-demographic factors, risk factors for acquiring STIs and vaccination status against HPV. Sampling was done for convenience. The variables related to sexual behavior and risk factors for acquiring HPV infection and other STIs were categorized by assigning measurement values. The SPSS program was used to analyze the data.

Results: Twenty-three percent (23.8%) of students reported that they had received the HPV vaccine. The majority of the unvaccinated female students had more than three sexual partners (P = 0.001), did not use condoms (P = 0.015) and used hormonal contraceptives (P = 0,018). Additionally, the majority of students vaccinated were under 20 years of age (P = < 0.001).

Conclusions: the majority of unvaccinated students often are at a higher risk of acquiring HPV infection and other STIs.

|Abstract

= 1788 veces | PDF (ESPAÑOL (ESPAÑA))

= 631 veces|

Downloads

Download data is not yet available.

Author Biographies

Erika andrea Sanchez Cifuentes, University of Antioquia

Microbiologist and Bioanalyst, School of Microbiology, University of Antioquia.

Natalie Patiño Cardenas, University of Antioquia

Microbiologist and Bioanalyst, School of Microbiology, University of Antioquia.

Juliana Espinosa Moncada, University of Antioquia

Microbiologist and Bioanalyst, School of Microbiology, University of Antioquia.

Lorena Quintero Murillo, University of Antioquia

Microbiologist and Bioanalyst, School of Microbiology, University of Antioquia.

Astrid Bedoya, University of Antioquia

Professor at the School of Microbiology. Bacteriologist and Clinical Laboratory Technician. DrSc. in Basic Biomedical Sciences, emphasis in Immunology. Molecular Microbiology Group, School of Microbiology, University of Antioquia.

References

Organización Mundial de la Salud. Infecciones de transmisión sexual. [Internet]. 2016 [Consultado 2017 May 10]. Disponible en: http://www.who.int/media-centre/factsheets/fs110/es/

Centers for Disease Control and Prevention. Sexua-lly transmitted diseases treatment guidelines. MMWR Recomm Rep. 2015;64(3):1-135

.3. Organización Mundial de la Salud. Guías. para el tratamiento de las infecciones de transmisión sexual. Suiza: OMS; 2005.

Colombia. Ministerio de Salud y Protección Social. Situación de las Infecciones de Transmisión Sexual di-ferentes al VIH. Colombia 2009-2011 [Internet]. 2011 [Consultado 2017 May 10]. Disponible en: https://www.minsalud.gov.co/salud/Documents/observato-rio_vih/documentos/monitoreo_evaluacion/1_vigi-lancia_salud_publica/a_situacion_epidimiologica/SI-TUACION DE LAS INFECCIONES DE TRANSMISION1.pdf

Tamayo L, López M, Villegas A, Agudelo C, Arrubla M, Muñoz J. Determinantes de salud sexual e ITS en adolescentes rurales, escolarizados, Medellín, Colom-bia. Rev Fac Nac Salud Pública. 2011;5:8-21.

Organización Mundial de la Salud. Papilomavirus humanos (PVH) y cáncer cervicouterino. WHO [Inter-net]. 2015 [consultado 2017 May 10]; Disponible en: http://www.who.int/mediacentre/factsheets/fs380/es/

OPS/OMS. Pruebas de VPH para el Tamizaje del Cán-cer Cervicouterino [Internet]. [Consultado 2017 May 10]. Disponible en: https://www.paho.org/hq/index.php?option=com_content&view=article&id=11925:hpv-tests-for-cervical-cancer-screening&Itemid=41948&lang=es

OMS. International Agency for Research on Cancer. Fact Sheets by Cancer [Internet]. [Consultado 2015 Oct 23]. Disponible en: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx

International Agency for Research on Cancer. Age standardized (World) mortality rates, cervix uteri, all ages [Internet]. 2018 [Consultado 2017 May 10]. Dis-ponible en: http://gco.iarc.fr/today/data/factsheets/cancers/23-Cervix-Uteri-fact-sheet.pdf

Chung CH, Bagheri A, D’Souza G. Epidemiology of oral human papillomavirus infection. Oral Oncol. 2014;50(5):364-9.

Tota JE, Chevarie-Davis M, Richardson LA, DeVries M, Franco EL. Epidemiology and burden of HPV infec-tion and related diseases: Implications for prevention strategies. Prev Med. 2011;53(Suppl. 1):12-21.

Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Cas-tellsagué X, Shah KV, et al. Epidemiologic Classifica-tion of Human Papillomavirus Types Associated with Cervical Cancer. N Engl J Med. 2003;27:518-27.

Serrano B, De Sanjosé S, Tous S, Quiros B, Mu-ñoz N, Bosch X, et al. Human papillomavirus ge-notype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. Eur J Cancer. 2015;51(13):1732-41.

Li N, Franceschi S, Howell-Jones R, Snijders PJF, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Varia-tion by geographical region, histological type and year of publication. Int J Cancer. 2011;128(4):927-35.

Muñoz N, Castellsagué X, de González AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vac-cine. 2006;24(Suppl. 3):1-10.

Crosbie EJ, Einstein MH, Franceschi S, KitchenerHC. Human papillomavirus and cervical cancer. Lancet. 2013;382(9895):889-99.

Bretagne CH, Jooste V, Guenat D, Riethmuller D, Bouvier AM, Bedgedjian I, et al. Prevalence and dis-tribution of HPV genotypes and cervical-associated le-sions in sexually active young French women following HPV vaccine. J Gynecol Obstet Hum Reprod. 2018;5-11.

Alizon S, Murall CL, Bravo IG. Why human papillo-mavirus acute infections matter. Viruses. 2017;9(10). doi:10.3390/v9100293.

Parkin DM, Bray F. The burden of HPV-related cancers. Vaccine. 2006;24:S11-25.

Roset Bahmanyar E, Paavonen J, Naud P, Salmerón J, Chow SN, Apter D, et al. Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRI-CIA trial. Gynecol Oncol. 2012;127(3):440-50.

Corona F, Peralta E. Prevención de conductas de ries-go. Rev Médica Clínica Las Condes. 2011;22(1):68-75.

Hansen BT, Kjær SK, Arnheim-Dahlström L, Liaw K-L, Jensen KE, Thomsen LT, et al. Human papilloma-virus (HPV) vaccination and subsequent sexual beha-viour: Evidence from a large survey of Nordic women. Vaccine. 2014;32(39):4945-53.

Ruiz-Sternberg ÁM, Pinzón-Rondón ÁM. Risk per-ception and sexual behavior in HPV-vaccinated and unvaccinated young Colombian women. Int J Gynecol Obstet. 2014;126(3):205-8.

Muñoz N, Méndez F, Posso H, Molano M, van den Brule AJC, Ronderos M, et al. Incidence, duration, and determinants of cervical human papillomavirus in-fection in a cohort of Colombian women with normal cytological results. J Infect Dis. 2004;190(12):2077-87.

Molano M, Posso H, Weiderpass E, van den Brule AJC, Ronderos M, Franceschi S, et al. Prevalence and determinants of HPV infection among Colombian wo-men with normal cytology. Br J Cancer. 2002;87:324-33. 26. Chelimo C, Wouldes TA, Cameron LD, Mark Elwood J, Elwood JM. Risk factors for and prevention of hu-man papillomaviruses (HPV), genital warts and cervical cancer. J Infect. 2013;66(3):207-17.

Brunia L, Castellsagué Piqué X, Bosch José FX. Vacu-nas frente al virus del papiloma humano. Enferm Infecc Microbiol Clin. 2014;26(Supl 1):65-77.

Bosch FX, Moreno D, Redondo E, Torné A. Vacuna nonavalente frente al virus del papiloma humano. Ac-tualización 2017. Semergen. 2017;22(2):129-43.

Morales LLA, Rincón RDF, Rincón Orozco B. Advan-ces in the development of new prophylactic and the-rapeutic vaccines against Human Papillomavirus. Rev Univ Ind Santander Salud. 2016;48(3):385-91.

Munoz N, Kjaer SK, Sigurdsson K, Iversen OE, Her-nandez-Avila M, Wheeler CM, et al. Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women. JNCI J Natl Cancer Inst. 2010;102(5):325-39.

Colombia. Ministerio de Salud y Protección Social de Colombia. Justificación de Vacunación contra el Virus del Papiloma Humano (VPH)-Colombia 2013. Esquema Altern Vacunación contra VPH. 2013;(32):3.

Colombia. Ministerio de Salud y Protección Social. Vacuna contra el cáncer de cuello uterino [Internet]. [Consultado 2015 Oct 3]. Disponible en: https://www.minsalud.gov.co/Paginas/ABC-de-la-vacuna-contra-el-cancer-cuello-uterino.aspx

Sopracordevole F, Cigolot F, Mancioli F, Agarossi A, Boselli F, Ciavattini A. Knowledge of HPV infection and vaccination among vaccinated and unvaccinated teenaged girls. Int J Gynecol Obstet. 2013;122(1):48-51. 34. Licht AS, Murphy JM, Hyland AJ, Fix BV, Hawk LW, Mahoney MC. Is use of the human papillomavirus vac-cine among female college students related to human papillomavirus knowledge and risk perception? Sex Transm Infect. 2010;86(1):74-8.

Forster AS, Marlow LAV, Stephenson J, Wardle J, Waller J. Human papillomavirus vaccination and se-xual behaviour: Cross-sectional and longitudinal sur-veys conducted in England. Vaccine. 2012;30(33):4939-44. 36. Rysavy MB, Kresowik JD, Liu D, Mains L, Lessard M, Ryan GL. Human papillomavirus vaccination and se-xual behavior in young women. J Pediatr Adolesc Gy-necol. 2014;27(2):67-71.

Liddon NC, Leichliter JS, Markowitz LE. Human papi-llomavirus vaccine and sexual behavior among adoles-cent and young women. Am J Prev Med. 2012;42(1):44-52.